Capitolis Appoints Roy Saadon as Head of Market Development, Portfolio Optimization January 6, 2026 Fintech executive and serial entrepreneur with 25 years’ experience to lead product adoption and expansion into new markets
Loomis Sayles Proudly Celebrates 100 Years of Client Commitment and Investment Excellence January 6, 2026 Loomis, Sayles & Company, the investment manager with $425 billion in assets under managementi, proudly marks its centennial year, celebrating a legacy of independent thinking and a relentless commitment to helping clients achieve their goals. Founded in January 1926, Loomis Sayles has grown to serving over 1,000 institutional clients in 28 countries offering differentiated investment [...]
Paris Saint-Germain Partners With Zing Coach Until 2027 to Encourage Fans to Get Active Through Interactive Fitness Experiences January 6, 2026 Paris Saint-Germain’s global fanbase will be offered the chance to engage in training routines modeled after their favorite Women and Men star players through Zing Coach’s AI-powered fitness platform, with top performers receiving exclusive experiences and prizes
Ikarovec to Advance Pipeline With Exclusive Worldwide Option to VectorBuilder’s Intravitreal Capsid Technology January 6, 2026 Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening disease
Kashiv BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conference January 6, 2026 Kashiv BioSciences, LLC (“Kashiv”), a vertically integrated biopharmaceutical company, today announced that Dr. Sandeep Athalye, Global Chief Executive Officer, and Dr. Paras Vasanani, Head of Business Development, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 14, 2026, at 11:00 a.m. PST. 44th Annual J.P. Morgan Healthcare [...]
Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium January 6, 2026 Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% for 10 patients with HER2+ oesophageal cancer who had received prior therapy that included a trastuzumab component in at least one prior treatment
Abu Dhabi’s TII Launches Falcon-H1 Arabic, Establishing the World’s Leading Arabic AI Model January 5, 2026 Based on new hybrid-architecture, models deliver higher accuracy while running on smaller parameter sizes Launch underscores UAE push to compete with global AI leaders in high-performance language models
Westlake Strengthens Global Compounds Portfolio With Acquisition of ACI Compounding Solutions Business January 5, 2026 Westlake Corporation (NYSE: WLK) (“Westlake”) announced today that it has completed the acquisition of the global compounding solutions businesses of the ACI/Perplastic Group (collectively, “ACI”). Headquartered in Portugal, ACI is a global manufacturer of specialty materials, primarily serving the wire and cable sectors. “The integration of ACI with Westlake’s compounding operations represents a strong strategic [...]
WP Engine Appoints Google Veteran Thierry Muller as Vice President of AI Products January 5, 2026 Accomplished leader brings extensive technical acumen, artificial intelligence experience and a strong track record of driving innovation
TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models January 5, 2026 Falcon H1R 7B Packs Advanced Reasoning into a Compact 7 Billion Parameter Model Optimized for Speed and Efficiency TII’s Latest AI Model Outperforms Larger Rivals from Microsoft, Alibaba, and NVIDIA on Key Benchmarks